Child Health

2 Active
18 Finished

20 results

Active
Pharmacogenetic determinates of the Response to Risperidone Among Children with Autism Spectrum Disorder
AL-Moamari, W. (PI)
1/1/24 → 1/31/25
Project: Internal Grants (IG)
An open‐label extension study to evaluate the long‐term safety, tolerability and efficacy of Marstacimab prophylaxis in severe (coagulation factor activity <1%) hemophilia A participants with or without inhibitors or moderately severe to severe hemophilia B participants (coagulation factor Activity ≤2%) with or without inhibitors
Wali, Y. (PI)
3/1/21 → …
Project: Other project
Finished

Convalescent plasma in the treatment of COVID-19: a controlled clinical trial
Lkhattab Ghalib Alhinai, Z. A. (PI)
6/4/20 → 6/3/21
Project: MoHERI
MALFORMATIONS OF CORTICAL DEVELOPMENT ? NEUROLOGICAL, EEG, MRI AND GENETIC CHARACTERISTICS
AL-Futaisi, A. (PI)
2/1/19 → 1/31/21
Project: Internal Grants (IG)
A single-arm interventional phase IV, post-authorization study evaluation the safety of pediatric patients with transfusional hemosiderosis treated with deferasirox crushed film coated tablets
Wali, Y. (PI)
1/1/17 → 12/31/20
Project: Deanship of Research Grants
A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Explore Efficacy and Safety of Sevuparin Infusion for the Management of Acute VasoOcclusive Cvisis(VOC) in Subjects with Sickle-Cell Disease (SCD).
Wali, Y. (PI)
1/1/17 → 12/31/18
Project: Deanship of Research Grants
A Randomized open label multi-center, two arm phase ll study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload
Wali, Y. (PI)
1/1/16 → 12/31/18
Project: HM Grants ( Strategic)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (purified poloxamer 188) Injection in Children with Sickle Cell Disease Experiencing Vaso-occlusive Crisis
Wali, Y. (PI)
1/1/14 → 12/31/16
Project: Other project
An open label study to evaluate prophylaxis, treatment and to characterize the efficacy, safety and phamacokinetics of B-domain deleted recombinant factor VIII al bumin free in children with hemophilia
Wali, Y. (PI)
1/1/14 → 12/31/17
Project: HM Grants ( Strategic)
Assessment of systolic, diastolic function and development of pulmonary hypertension in children with ?-Thalassemia Intermedia and Sickle Cell Disease (SCD) using conventional and tissue Doppler echocardiography
Wali, Y. (PI)
1/1/14 → 12/31/16
Project: Internal Grants (IG)
Descriptive Study of Sickle Cell Disease Risk Factors and Magnitude in the Gulf Region Based on TCD Values
Wali, Y. (PI)
1/1/13 → 12/31/15
Project: HM Grants ( Strategic)
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries ( Study ID HAEM - 3971)
Wali, Y. (PI)
1/1/13 → 12/31/13
Project: HM Grants ( Strategic)
KAPPA?(Key Aspects of medical Practice in Patients with Haemophilia A)
Wali, Y. (PI)
1/1/13 → 12/31/16
Project: HM Grants ( Strategic)
Genetic Causes of Primary Immunodeficiency Disorders in Omani Patients
Al-Tamemi, S. (PI)
1/1/13 → 12/31/14
Project: Internal Grants (IG)
CLINICAL AND GENETIC CHARACTERISTICS OF HbS_OMAN: A SEVERE UNREVEALED FORM OF SICKEL CELL DISEASE
Wali, Y. (PI)
1/1/13 → 12/31/16
Project: Internal Grants (IG)
Enuresis in children ? biochemical and psychosocial factors
Al Saadoon, M. (PI)
1/1/12 → 12/31/12
Project: Internal Grants (IG)
Genetics of Systemic Lupus Erythematosus
Abdawani, R. (PI)
1/1/12 → 12/31/12
Project: Internal Grants (IG)
Prospective Observational Study on the Home Treatment of Haemarthrosis with rFVlla in Haemophilia A and B Patients with Inhibitors"
Wali, Y. (PI)
1/1/11 → 12/31/11
Project: HM Grants ( Strategic)
Genetic causes of congenital neutropenia
Wali, Y. (PI)
1/15/10 → 1/14/11
Project: Internal Grants (IG)
Genetic predictors of stroke in patients with sickle cell disease
Wali, Y. (PI)
1/1/07 → 12/31/07
Project: Collaborative Project